Lakefront Biotherapeutics (LKFT) Net Margin Growth (3y) (2017 - 2026)
Lakefront Biotherapeutics (LKFT) Net Margin Growth (3y) (2017 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 9,283.00 |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 506.00 |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | -569.00 |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 6,537.00 |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | Lakefront Biotherapeutics | 1.85 Bn | -1.64 Bn | 1.91 Mn | 18,399.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 18,399.00 |
| Dec 31, 2025 | 20,146.00 |
| Sep 30, 2025 | -8,311.00 |
| Jun 30, 2025 | 8,867.00 |
| Mar 31, 2025 | -11,224.00 |
| Dec 31, 2024 | 24,414.00 |
| Sep 30, 2024 | 249,462.00 |
| Jun 30, 2024 | 2,847.00 |
| Mar 31, 2024 | 14,450.00 |
| Dec 31, 2023 | 17,375.00 |
| Sep 30, 2023 | 9,280.00 |
| Jun 30, 2023 | 12,400.00 |
| Mar 31, 2023 | 8,846.00 |
| Dec 31, 2022 | -886.00 |
| Sep 30, 2022 | 3,775.00 |
| Jun 30, 2022 | -1,022.00 |
| Mar 31, 2022 | 5,487.00 |
| Dec 31, 2021 | -3,602.00 |
| Sep 30, 2021 | -253,695.00 |
| Jun 30, 2021 | -8,985.00 |